Commonplace pharmaceuticals, such as ibuprofen, can carry with them an inherent flaw in their atomic structure, which pairs the active, beneficial ingredient with a potentially ineffective—or even toxic—counterpart. New research could hold the key to more easily isolating the good while removing the unwanted.